Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets 2021: Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Landscape

Saturday, November 18, 2017 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Nov. 17, 2017 /PRNewswire/ -- Complete report $4,850.  DataPack (test volumes,

sales forecasts, supplier shares) $2,850The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.

Read the full report:


new five-country study from LeadingMarketResearch contains 495 pages, 28 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.

Report Highlights

- Market shares of leading suppliers- Business and technological trends in major markets- Five-year test volume and sales forecasts- Market shares of leading competitors- Feature comparison of major analyzers- Strategic profiles of leading market players and start-up firms developing innovative products- Specific product and business opportunities for instrument and consumable suppliers.


Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry.  The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.  The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.  In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.  Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

- France- Germany- Italy- Spain- UK

European Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment.

- Five-year test volume and sales projections by country.

Market Segmentation Analysis

- Five-year test volume and sales projections:

- Infectious Diseases        - Forensic Testing- Cancer                            - Paternity Testing/HLA Typing- Genetic Diseases            - Others

- A comprehensive analysis of the sequencing market by country and laboratory segment.- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country.

Product/Technology Review

- Comparison of the major molecular diagnostic analyzers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and target/signal amplification methods.

- Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in RandD.   - Abbott   - Affymetrix   - Agilent Technologies   - Applied Gene Technologies   - Arca Biopharma   - Beckman Coulter/Danaher   - Becton Dickinson   - Biokit   - BioMerieux   - Bio-Rad   - Biotest   - Cepheid   - CellMark Forensics/LabCorp   - Decode Genetics    - Diadexus    - Eiken   - Elitech Group   - Enzo   - Exact Sciences   - Fujirebio   - Grifols   - Hologic/Gen-Probe   - Illumina   - Kreatech/Leica   - Li-Cor Biosciences   - Life Technologies/Thermo Fisher   - Monogram Biosciences   - Myriad Genetics   - Ortho-Clinical Diagnostics   - Perkin Elmer/Caliper   - Proteome Sciences   - Qiagen                  - Roche   - Scienion   - Sequenom   - Shimadzu   - Siemens   - Sierra Molecular   - Takara Bio   - Tecan Group   - Thermo Fisher

- Comprehensive listings of companies developing and marketing molecular diagnostic products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Contains 495 pages and 28 tables

Read the full report: About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001

View original content:

SOURCE Reportlinker


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store